|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 63.96 CHF | +0.35% |
|
+0.41% | +1.07% |
| 01-15 | Staar Surgical CEO to exit as part of deal with top shareholder | RE |
| 01-13 | Alcon Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-13-2026 08:15 AM |
| Capitalization | 39B 33.62B 31.3B 29.14B 54.26B 3,539B 58.37B 360B 142B 1,688B 146B 143B 6,164B | P/E ratio 2025 * |
38.6x | P/E ratio 2026 * | 36.9x |
|---|---|---|---|---|---|
| Enterprise value | 41.79B 36.03B 33.54B 31.22B 58.14B 3,792B 62.55B 386B 152B 1,809B 157B 153B 6,604B | EV / Sales 2025 * |
4.03x | EV / Sales 2026 * | 3.66x |
| Free-Float |
98.82% | Yield 2025 * |
0.41% | Yield 2026 * | 0.44% |
Last Transcript: Alcon Inc.
| 1 day | +0.58% | ||
| 1 week | +0.41% | ||
| Current month | +1.07% | ||
| 1 month | +2.37% | ||
| 3 months | +6.18% | ||
| 6 months | -7.01% | ||
| Current year | +1.07% |
| 1 week | 63.18 |  | 65.16 |
| 1 month | 61.92 | | 65.7 |
| Current year | 61.92 | | 65.7 |
| 1 year | 57.68 | | 87 |
| 3 years | 57.68 | | 87 |
| 5 years | 55.22 | | 87 |
| 10 years | 38.62 | | 87 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Endicott
CEO | Chief Executive Officer | 60 | 2018-06-30 |
| Director of Finance/CFO | 58 | 2019-04-07 | |
Patrick Collier
CTO | Chief Tech/Sci/R&D Officer | - | 2024-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
David Endicott
BRD | Director/Board Member | 60 | - |
F. Ball
CHM | Chairman | 70 | 2018-06-30 |
Lynn Bleil
BRD | Director/Board Member | 63 | 2019-01-31 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -.--% | 3.96% | 121 M€ | |
| +1.50% | 1.24% | 26 M€ | |
| +3.97% | 0.41% | 1,101 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.35% | +0.41% | -16.33% | -7.65% | 39B | |
| -3.90% | -2.48% | +12.82% | +55.97% | 151B | |
| +0.24% | -1.06% | -10.29% | -4.36% | 16.13B | |
| -1.42% | +0.85% | - | - | 8.79B | |
| +10.52% | +11.96% | +150.62% | +1,190.60% | 3.36B | |
| -1.26% | +0.99% | -1.80% | -56.92% | 2.13B | |
| -2.01% | +5.77% | +13.72% | +3.35% | 1.32B | |
| 0.00% | +0.50% | +17.52% | -39.36% | 753M | |
| -0.88% | -2.41% | -20.73% | -36.12% | 705M | |
| Average | +0.21% | +0.07% | +18.19% | +138.19% | 24.8B | |
| Weighted average by Cap. | -2.45% | +2.05% | +7.71% | +55.57% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 10.37B 8.94B 8.32B 7.75B 14.42B 941B 15.52B 95.7B 37.73B 449B 38.88B 38.07B 1,638B | 11.1B 9.57B 8.9B 8.29B 15.43B 1,007B 16.61B 102B 40.39B 480B 41.61B 40.75B 1,753B |
| Net income | 1.04B 900M 837M 780M 1.45B 94.67B 1.56B 9.63B 3.8B 45.16B 3.91B 3.83B 165B | 1.08B 933M 869M 809M 1.51B 98.19B 1.62B 9.99B 3.94B 46.84B 4.06B 3.97B 171B |
| Net Debt | 2.79B 2.4B 2.24B 2.08B 3.88B 253B 4.18B 25.75B 10.15B 121B 10.46B 10.25B 441B | 1.59B 1.37B 1.28B 1.19B 2.21B 144B 2.38B 14.7B 5.8B 68.9B 5.97B 5.85B 252B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-01-16 | 63.96 CHF | +0.35% | 1,148,680 |
| 26-01-15 | 63.74 CHF | 0.00% | 817,747 |
| 26-01-14 | 63.74 CHF | -1.12% | 1,007,776 |
| 26-01-13 | 64.46 CHF | +0.06% | 925,268 |
| 26-01-12 | 64.42 CHF | +1.13% | 783,301 |
Delayed Quote Swiss Exchange, January 16, 2026 at 11:31 am
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ALC Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition